MS Phase 3 study Baclofen ER: uses & side-effects

PatientsLikeMe would like to remind you that your browser is out of date and many features of the website may not function as expected. Please update your browser for more security and a better experience.

Skip over navigation

Filter by patients with:

Start typing to see suggestions

What is MS Phase 3 study Baclofen ER?

Category: Others

NCT01457352 is a randomized, placebo-controlled study to evaluate safety and efficacy of an extended release version of baclofen for treating muscle spasticity in patient with multiple sclerosis. Other study names are CLR_09_21.

See patients taking MS Phase 3 study Baclofen ER

Last updated: April 25, 2026

There are no evaluations for MS Phase 3 study Baclofen ER.

▲ Back to top